Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-01-09 @ 4:39 AM
Study NCT ID:
NCT03715933
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2018-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Sponsor:
Inhibrx Biosciences, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Ph1 INBRX-109
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None